...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
【24h】

Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.

机译:用体外细胞毒性方法代替体内急性口腔毒性研究:机会,限制和调节状态。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The development of a new medicinal product is a long and costly process in particular due to the regulatory requirements for quality, safety and efficacy. There is a common interest to increase the efficiency of drug development and to provide new, better quality medicinal products much faster to the public. One possible way to economize time and costs, as well as to consider animal protection issues, is to introduce new alternative methods into non-clinical toxicity testing. Currently, animal tests are mandatory for the evaluation of acute toxicity of chemicals and new drugs. The replacement of the in vivo tests by alternative in vitro assays would offer the opportunity to screen and assess numerous compounds at the same time, to predict acute oral toxicity and thus accelerate drug development. Moreover, the substitution of in vivo tests by in vitro methods shows a proactive pursuit of ethical and animal welfare issues. Importantly, the implementation of in vitro assays for acute oral toxicity would require the establishment of common test guidelines across the EU, USA and Japan, i.e., the regions of ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use). Presently, alternative in vitro tests are being investigated internationally. Yet, in order to achieve regulatory acceptance and implementation of in vitro assays, convincing results from validation studies are required. In this review, we discuss the current regulatory status of acute oral toxicity testing and point out achievements of alternative methods. We describe the application of in vitro tests, correlating in vitro with in vivo data. The use of in vitro data to predict in vivo acute oral toxicity is analyzed using the Registry of Cytotoxicity, an official independent database. We have then analyzed opportunities and drawbacks for future implementation of in vitro test methods, with particular focus on industrial use.
机译:新药品的开发是一个漫长而昂贵的过程,特别是由于对质量,安全性和功效的监管要求。提高药物开发效率并以更快的速度向公众提供新的,质量更高的医药产品是人们的共同利益。节省时间和成本以及考虑动物保护问题的一种可能方法是在非临床毒性测试中引入新的替代方法。目前,动物试验对于评估化学品和新药的急性毒性是强制性的。用替代的体外试验代替体内试验将提供机会同时筛选和评估多种化合物,以预测急性口服毒性并因此加速药物开发。此外,用体外方法代替体内测试显示出对道德和动物福利问题的积极追求。重要的是,实施急性口服毒性的体外分析将需要在欧盟,美国和日本(即ICH(国际人用药品注册技术要求统一会议)地区)之间建立通用的测试指南。目前,国际上正在研究替代性体外测试。但是,为了获得监管机构的认可和体外测定的实施,需要有令人信服的验证研究结果。在这篇综述中,我们讨论了急性口腔毒性测试的当前监管状况,并指出了替代方法的成就。我们描述了体外测试的应用,将体外数据与体内数据相关联。使用官方独立数据库“细胞毒性注册表”分析了体外数据在体内预测急性口服毒性的作用。然后,我们分析了未来实施体外测试方法的机会和弊端,特别是工业用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号